Inovio and Wistar team up for DNA-based immunotherapies
16 March 2016 | By Victoria White
Inovio and the Wistar Institute are to research preventive and therapeutic DNA-based immunotherapies for cancers and infectious diseases...
List view / Grid view
16 March 2016 | By Victoria White
Inovio and the Wistar Institute are to research preventive and therapeutic DNA-based immunotherapies for cancers and infectious diseases...
16 March 2016 | By Victoria White
Sanofi and DiCE Molecules have entered a five-year global collaboration to discover potential new therapeutics for up to 12 targets...
16 March 2016 | By Victoria White
JLINX is designed to catalyse scientific innovations by offering start-ups flexible ways to grow and collaborate across the European life science ecosystem...
15 March 2016 | By Victoria White
A division of SRI International will conduct preclinical studies to assess the efficacy of compounds or vaccines for preventing invasive-cancer development...
15 March 2016 | By Victoria White
Under a collaboration with Roche, Blueprint Medicines will lead preclinical research and development through to Phase I proof of concept...
15 March 2016 | By Victoria White
Their work could help unravel how and why people develop Parkinson’s, and aid in the search for potential treatments...
15 March 2016 | By Victoria White
Outpost Medicine is a biopharmaceutical company focused on the development of new treatments of urologic and gynaecologic diseases and disorders...
14 March 2016 | By Victoria White
After three weeks' treatment with HXR9, human mesothelioma tumours in mice stopped growing, with a complete loss of tumour blood vessels and widespread cancer cell death...
14 March 2016 | By Victoria White
Dr Weiner was co-founder with J. Joseph Kim, Ph.D., Inovio’s CEO, of VGX Pharmaceuticals in 2000; via merger VGX later became Inovio Pharmaceuticals...
14 March 2016 | By Victoria White
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, has appointed Dr Geoff Smith as CEO...
13 March 2016 | By Victoria White
A group of researchers has taken a step toward a male contraceptive pill by tweaking some experimental compounds that show promise...
11 March 2016 | By Victoria White
Scancell is to collaborate with the Karolinska Institutet to explore the scientific and clinical role of citrullinated proteins in the treatment of cancer...
11 March 2016 | By Victoria White
Trioxacarcins disrupt the replication of cancer cells by binding and chemically modifying their genetic material...
10 March 2016 | By Victoria White
Scientists are a step closer to creating blood stem cells that could reduce the need for bone marrow transplants in patients with cancer or blood disorders...
10 March 2016 | By
This graphic depicts a new inhibitor, 6S, locking up an enzyme (red) to block the production of hydrogen sulfide (yellow and white). Hydrogen sulfide concentrations have been shown to climb after the onset of a stroke, leaving to brain damage. CREDIT: Matthew Beio, University of Nebraska-Lincoln Researchers have developed a…